EQUASIA Trademark
Trademark Overview
On Tuesday, January 29, 2002, a trademark application was filed for EQUASIA with the United States Patent and Trademark Office. The USPTO has given the EQUASIA trademark a serial number of 78105364. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 6, 2003. This trademark is owned by WELLQUEST INTERNATIONAL, INC.. The EQUASIA trademark is filed in the Pharmaceutical Products category with the following description:
herbal supplements
General Information
Serial Number | 78105364 |
Word Mark | EQUASIA |
Filing Date | Tuesday, January 29, 2002 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, January 6, 2003 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | herbal supplements |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, February 14, 2002 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | WELLQUEST INTERNATIONAL, INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10001 |
Trademark Events
Event Date | Event Description |
Monday, January 6, 2003 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Thursday, January 2, 2003 | ASSIGNED TO EXAMINER |
Saturday, May 4, 2002 | NON-FINAL ACTION E-MAILED |
Friday, May 3, 2002 | ASSIGNED TO EXAMINER |